BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2017
View Archived Issues
ITUS enters research agreement with Moffitt Cancer Center
Read More
European Commission approves Tesaro's Zejula
Read More
Genexine's recombinant human erythropoietin effective in patients on dialysis
Read More
Selective nSMase2 inhibitor MS-882 shows promise for Alzheimer's disease
Read More
Orexo's Zubsolv approved for opioid dependence in Europe
Read More
FDA orphan and breakthrough therapy designations awarded to PellePharm for patidegib
Read More
FDA grants breakthrough therapy designation to patisiran
Read More
Indication for Zytiga expanded in Europe
Read More
FDA gives fast track status to lumateperone for treatment of schizophrenia
Read More
CX-549's neuroprotective effects demonstrated in a rat model of stroke
Read More
OphthaliX completes merger with Wize Pharma
Read More
FDA grants orphan drug designation to Revance's daxibotulinumtoxin A for cervical dystonia
Read More
Adocia reports phase I results for BioChaperone Glucagon
Read More
Melinta Therapeutics presents compounds for treating bacterial infections
Read More
Janssen applies to expand indication for Imbruvica in Japan
Read More
Novel glucosylceramidase activators presented by Lysosomal Therapeutics
Read More
Full U.S. commercial launch for Zilretta
Read More
Incyte discloses hPD-1 signaling inhibitors
Read More
First patient enrolled in pivotal study of Daiichi Sankyo's DS-8201
Read More
EMA announces relocation to the Netherlands
Read More
Calliditas Therapeutics gives update on phase III study plans for Nefecon
Read More
Calico Life Sciences and AbbVie patent new EIF2B activators
Read More
Bayer Pharma identifies vasopressin receptor antagonists
Read More